| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 137,602 | 128,100 | 124,663 | 118,912 | | Cost of Revenue | 96,290 | 94,700 | 94,207 | 93,431 | | | Gross Profit | 41,312 | 33,400 | 30,456 | 25,481 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,978 | 15,167 | 17,243 | 16,809 | | Non Recurring | 533 | (604) | 71 | (287) | | Others | 4,758 | 4,629 | 4,589 | 4,462 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,815 | 14,208 | 8,553 | 4,497 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,707 | 941 | 822 | 763 | | Earnings Before Interest And Taxes | 21,750 | 15,149 | 9,375 | 5,260 | | Interest Expense | 1,285 | 1,123 | 1,235 | 1,254 | | Income Before Tax | 20,465 | 14,026 | 8,140 | 4,006 | | Income Tax Expense | 7,861 | 5,374 | 3,152 | 270 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,604 | 8,652 | 4,988 | 3,736 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,604 | 8,652 | 4,988 | 3,736 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,604 | $8,652 | $4,988 | $3,736 |
|
1.52% Nasdaq 0.00%
Income Statement
